Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Zeljko Jonjic"'
Autor:
Josip Batinić, Barbara Dreta, Goran Rinčić, Antonia Mrdeža, Karla Mišura Jakobac, Delfa Radić Krišto, Milan Vujčić, Mario Piršić, Željko Jonjić, Vlatka Periša, Jasminka Sinčić Petričević, Božena Coha, Hrvoje Holik, Toni Valković, Marija Stanić, Ivan Krečak, Ante Stojanović, Domagoj Sajfert, Sandra Bašić-Kinda
Publikováno v:
Medicina, Vol 60, Iss 11, p 1905 (2024)
Background and Objectives: Ixazomib, used in combination with lenalidomide and dexamethasone (IRd), has shown efficacy in clinical trials for relapsed/refractory multiple myeloma (RRMM). Materials and Methods: This study evaluates the real-world effe
Externí odkaz:
https://doaj.org/article/1a2111b124bb4a0398e372012d9af279
Autor:
Marko Lucijanic, Vlatko Pejša, Ozren Jakšić, Zeljko Prka, Marija Ivic, Zdravko Mitrović, Mario Piršić, Zeljko Jonjic, Anamarija Vrkljan Vuk, Tajana Štoos-Veić, Amina Fazlic Dzankic
First obinutuzumab application is associated with infusion related reactions (IRRs) that may discourage further continuation of the drug. During our clinical practice we have observed that chronic lymphocytic leukemia (CLL) patients with autoimmune h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::984d67b2e6cf2c1ca499322a39f765b3
https://urn.nsk.hr/urn:nbn:hr:105:272145
https://urn.nsk.hr/urn:nbn:hr:105:272145
Autor:
Tajana Štoos-Veić, Marko Lucijanic, Zeljko Jonjic, Rajko Kusec, Marija Ivic, Katarina Marija Tupek, Amina Fazlic Dzankic, Vlatko Pejša, Ana Livun
Publikováno v:
Wiener klinische Wochenschrift. 132(15-16)
This study retrospectively analyzed glioma-associated oncogene 1 (GLI‑1) mRNA expression in unfractionated bone marrow aspirates of 32 patients with myelofibrosis and 16 controls. It was found that GLI‑1 expression did not significantly differ be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dec849b46d6012eff754a94a098bc6b
https://pubmed.ncbi.nlm.nih.gov/31712882
https://pubmed.ncbi.nlm.nih.gov/31712882
Autor:
Zeljko Jonjic, Amina Fazlic Dzankic, Marko Lucijanic, Rajko Kusec, Marija Ivic, Tajana Štoos-Veić, Vlatko Pejša, Ana Livun
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S347-S348
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d457f5039bf5922980781b474b804b79
https://doi.org/10.1016/j.clml.2019.07.357
https://doi.org/10.1016/j.clml.2019.07.357
Unique case of PML after obinutuzumab treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4068c0e83295f1805304f63a14c71f3c
https://doi.org/10.1007/s00277-018-3552-x
https://doi.org/10.1007/s00277-018-3552-x
Autor:
Vlatko Pejša, Ana Livun, Tajana Štoos-Veić, Marko Lucijanic, Rajko Kušec, A. Fazlic Dzankic, Zeljko Jonjic, Marija Ivic
Publikováno v:
HemaSphere. 3:668
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdc5d9a43b3cc1b77130bef34c1508c1
https://doi.org/10.1097/01.hs9.0000564072.45275.b4
https://doi.org/10.1097/01.hs9.0000564072.45275.b4